FDA clears ‘rapid’ Terumo BCT collection system as demand for plasma-based therapies grows worldwide 22-Mar-2022 By Jane Byrne The US Food and Drug Administration (FDA) has cleared a new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company based in Colorado.